Laurel Organics Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹36.12
- Today's High:
- ₹38.98
- Open Price:
- ₹37.03
- 52W Low:
- ₹31.26
- 52W High:
- ₹48.95
- Prev. Close:
- ₹38.03
- Volume:
- 5629
Company Statistics
- Market Cap.:
- ₹1.43 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Laurel Organics Ltd had its IPO on under the ticker symbol 530313.
The company operates in the Other sector and Other industry. Laurel Organics Ltd has a staff strength of 96 employees.
Stock update
Shares of Laurel Organics Ltd opened at ₹37.03 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹36.12 - ₹38.98, and closed at ₹36.81.
This is a -3.21% slip from the previous day's closing price.
A total volume of 5,629 shares were traded at the close of the day’s session.
In the last one week, shares of Laurel Organics Ltd have increased by +8.81%.
Laurel Organics Ltd's Key Ratios
Laurel Organics Ltd has a market cap of ₹1.43 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Laurel Organics Ltd’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Laurel Organics Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Laurel Organics Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Laurel Organics Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Laurel Organics Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Laurel Organics Ltd’s profitability.
Laurel Organics Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Laurel Organics Ltd stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹1.21 billion
- Total Liabilities
- ₹763.98 million
- Operating Cash Flow
- ₹-27986000.00
- Capital Expenditure
- ₹28.12 million
- Dividend Payout Ratio
- 0%
Laurel Organics Ltd ended 2024 with ₹1.21 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹1.21 billion while shareholder equity stood at ₹54.63 million.
Laurel Organics Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹763.98 million in other current liabilities, 47313000.00 in common stock, ₹7.32 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹1.78 million and cash and short-term investments were ₹24.93 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹308.36 million.
Laurel Organics Ltd’s total current assets stands at ₹827.47 million while long-term investments were ₹0 and short-term investments were ₹19.95 million. Its net receivables were ₹305.90 million compared to accounts payable of ₹0 and inventory worth ₹482.34 million.
In 2024, Laurel Organics Ltd's operating cash flow was ₹-27986000.00 while its capital expenditure stood at ₹28.12 million.
Comparatively, Laurel Organics Ltd paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹36.81
- 52-Week High
- ₹48.95
- 52-Week Low
- ₹31.26
- Analyst Target Price
- ₹
Laurel Organics Ltd stock is currently trading at ₹36.81 per share. It touched a 52-week high of ₹48.95 and a 52-week low of ₹48.95. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹35.8 and 200-day moving average was ₹37.23 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Laurel Organics Ltd
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Laurel Organics Ltd manufactures and sells pharmaceutical-bulk drugs in India. The company offers Benfotiamine, Cilnidipine, Gliclazide, Levosulpride, Rosuvastatin Calcium, Tranexamic Acid, Benidipine, Teneligliptin Hydrate Hydrobromide, Acotiamide, Citicoline Sodium, Luliconazole, Deflazacort, Voglibose, Oxaceprol, Ursodeoxycholic Acid, Bacitracin Zinc, Isotretinoin, and Tretinoin, as well as vitamin B1, calcium channel blocker, central stimulant/nootropic agent, and choleretic agent. It also provides products for various therapeutic categories, which comprise antidiabetic, antipsychotic, antihyperlipidemic, hemostatic, antihypertensive, antidiabetic, antiemetic, anti-fungal, anti-inflammatory, and anti-acne. The company was incorporated in 1993 and is based in New Delhi, India. Laurel Organics Ltd is a subsidiary of Kimia Biosciences Ltd.